Transaction DateRecipientSharesTypePriceValue
Spherix logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

Spherix, Inc. is a biotechnology development company. The firm's activities include the acquisition and development of patents through internal or external research and development. Its patent portfolio consists of patents in the fields of wireless communications, satellite, solar and radio frequency.

Ticker: SPEX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 12239
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags